Markets
markets
J. Edward Moreno

Moderna rises on study suggesting COVID-19 shot enhances efficacy of cancer treatment

Moderna rose more than 5% on Monday after a new study showed that mRNA COVID-19 shots could enhance cancer immunotherapy.

The results were presented by researchers from MD Anderson Cancer Center at the European Society for Medical Oncology conference in Berlin on Sunday, Stat News and others reported. The study found that cancer patients who took the COVID-19 shot within 100 days of taking an immunotherapy drug lived longer.

Moderna was tapped by the first Trump administration alongside Pfizer to quickly develop an immunization for Covid in 2020. Moderna still makes nearly all of its revenue from the vaccine while Pfizer has a larger, more diversified portfolio. Moderna has other products in its pipeline, including a dual flu and COVID-19 vaccine and personalized cancer vaccines.

More Markets

See all Markets
markets
Matt Phillips

Robinhood 4Q revenue misses estimates, but earnings beat

Robinhood Markets posted fourth-quarter revenue that fell short of analysts’ estimates, but earnings topped Wall Street’s forecasts.

(Robinhood Markets Inc. is the parent company of Sherwood Media, an independently operated media company subject to certain legal and regulatory restrictions. I own Robinhood stock as part of my compensation.)

The stock, crypto, and options-trading platform reported:

  • Q4 earnings per share of $0.66 vs. analysts’ consensus estimate of $0.63, according to FactSet.

  • Sales of $1.28 billion vs. expectations of $1.35 billion.

  • Transaction-based revenue of $776 million vs. expectations of $797.6 million. 

Shares of the company were down 5.4% shortly after the report.

Robinhood shares notched gains of 193% and 204% in 2024 and 2025, respectively, though they’ve recently given up some of those gains amid volatility in the crypto markets.

J. Edward Moreno
10m
Lyft gives mixed earnings report, announces $1 billion buyback

Lyft — which is has a $6.7 billion market cap — announced that it would buyback up to $1 billion in shares.

Lyft decal
Tasha Matsumoto
14m
Stocks dip ahead of tomorrow’s delayed jobs report

After weaker than expected retail sales, Wall Street awaits tomorrow’s delayed jobs report and Friday’s delayed CPI for clues into the health of the economy.

CHICAGO, ILLINOIS - JANUARY 18: Caleb Williams #18 of the Chicago Bears throws a pass against the Los Angeles Rams during the first quarter in the NFC Divisional Playoffs at Soldier Field on January 18, 2026 in Chicago, Illinois.
markets
Luke Kawa

The tech sector’s biggest winners and losers are swapping places

It’s bizarro world for the tech sector.

Software stocks, the market’s collective whipping boy in 2026 in light of the presumptive threat of AI disruption, are continuing to recover on Tuesday. Meanwhile, the biggest winners of the AI boom this year — memory stocks, benefiting from intense shortages — are taking their turn in the red.

The iShares Expanded Tech Software ETF’s gains are being led by Datadog, a rare case of a software stock rising after reporting earnings this season, with heavyweights Oracle and ServiceNow outperforming the industry. Figma, which isn’t in this product, is also up double digits.

On the other side of the spectrum, Micron, Sandisk, Seagate Technology Holdings, and Western Digital are selling off.

The seesaw of modern markets often requires that as one group’s fortunes inflect positively after a long drubbing, so too must a high-flyer have its wings clipped.

That is, if you’re a portfolio manager long memory and short software stocks, and enough investors are willing to catch a falling knife and buy the beaten-down group, staying market-neutral and reducing this position would require you to purchase software and dump some memory stocks.

markets
Matt Phillips

Michael Burry flags bearish technical pattern in Palantir, says he’s “working on something”

Trader and widely followed Substacker Michael Burry, once of “The Big Short” fame, called out a bearish technical trend for Palantir in a post on X last night.

He spotlighted what he interprets as a “head and shoulders” pattern in the stock, considered a bearish omen among the international community of chart-watchers.

Along with that, he’s also mapped out Fibonacci retracement levels, another popular technical analysis tool to identify key prices the shares might fall to or rebound from. Burry’s chart highlights the level around $84 as the “Next Support” for the stock and $54.50 as the “Landing Area.”

Read more

Cassandra Unchained on X: "I am working on something $PLTR. https://t.co/PPETfScTkE" / X

Cassandra Unchained on X: "I am working on something $PLTR. https://t.co/PPETfScTkE" / X

Along with that, he’s also mapped out Fibonacci retracement levels, another popular technical analysis tool to identify key prices the shares might fall to or rebound from. Burry’s chart highlights the level around $84 as the “Next Support” for the stock and $54.50 as the “Landing Area.”

Read more

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.
©2026 Sherwood Media, LLC